Free tool

Oncology stocks

We cover 11 companies grouped under the Oncology theme. The median market value in the group is $4.34M. Across the group, the median move over the past trading day is −2.77%. Price change over the past year runs from −95.8% to −46.2% across the middle 80 percent of the group, with a median of −76.7%.

Other lists in this group

Table

11 of 319 companies match these filters.Clear filters

TickerCompanyMarket cap (USD)Size1Y return
KPTIKaryopharm Therapeutics Inc. Common Stock$44.46MMicro cap−74.90%
BYSIBeyondSpring Inc.$28.37MMicro cap−62.09%
LTRNLantern Pharma Inc.$27.87MMicro cap−46.17%
RADXRadiopharm Theranostics Limited$18.29MMicro cap−58.87%
PDSBPDS Biotechnology Corporation$12.49MMicro cap−82.56%
APVOAptevo Therapeutics Inc.$4.34MMicro cap−92.52%
CRISCuris, Inc.$3.86MMicro cap−5.52%
RNAZTransCode Therapeutics, Inc.$2.48MMicro cap−76.72%
SLXNSilexion Therapeutics Corp$1.97MMicro cap−95.11%
DCOYDecoy Therapeutics Inc.$1.95MMicro cap−95.78%
BDRXBiodexa Pharmaceuticals Plc$1.07MMicro cap−96.58%

Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.

More ways to browse